IgG3 (Middle Region) Peptid
Reaktivität: Human
Wirt: Synthetic
WB, BP
-
- Target Alle IgG3 Produkte
- IgG3
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Western Blotting (WB), Blocking Peptide (BP)
- Sequenz
- TKNQVSLTCL VKGFYPSDIA VEWESSGQPE NNYNTTPPML DSDGSFFLYS
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti- IGHG3 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
IgG3 peptide (Ovalbumin)
Reaktivität: Maus Wirt: Synthetic WB, Imm, SDS
IgG3 peptide (Ovalbumin)Reaktivität: Maus Wirt: Synthetic WB, Imm, SDS
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- IgG3
- Synonyme
- IgG3 Peptide, Immunoglobulin heavy constant gamma 3 Peptide, immunoglobulin heavy constant gamma 3 (G3m marker) Peptide, Ighg3 Peptide, IGHG3 Peptide
- Substanzklasse
- Antibody
- Hintergrund
-
Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens. The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen.
Alias Symbols: IgG3
Protein Size: 377 - Gen-ID
- 3502
- UniProt
- P01860
-
Sie sind hier:
